American Kidney Fund
American Kidney Fund’s Rare Kidney Disease Advocacy Day on Capitol Hill Seeks to Gather Support for Legislation that will Increase Awareness and Treatment of Rare Kidney Diseases
September 18, 2024 09:59 ET | American Kidney Fund
ROCKVILLE, Md., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Members of AKF’s Rare Kidney Disease Action Network (RKDAN) and health care professionals will visit Capitol Hill in Washington, D.C. today to meet...
American Kidney Fund
American Kidney Fund Hosts Annual National Summit on Unknown Causes of Kidney Disease
September 16, 2024 09:49 ET | American Kidney Fund
ROCKVILLE, Md., Sept. 16, 2024 (GLOBE NEWSWIRE) -- As part of its ongoing groundbreaking work to advance understanding and patient care of undiagnosed or misdiagnosed causes of kidney disease, the...
eledon-logo-1230.png
Eledon Pharmaceuticals to Present at the Cantor Global Healthcare Conference
September 11, 2024 16:05 ET | Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals to Present at the Cantor Global Healthcare Conference
eledon-logo-1230.png
Eledon Announces Completion of Enrollment in Phase 2 BESTOW Clinical Trial Assessing Tegoprubart for Prevention of Organ Rejection in Kidney Transplant Patients
September 04, 2024 07:00 ET | Eledon Pharmaceuticals, Inc.
Eledon Announces Completion of Enrollment in Phase 2 BESTOW Clinical Trial Assessing Tegoprubart for Prevention of Organ Rejection in Kidney Transplants
Boehringer Ingelheim
Boehringer Ingelheim and Eli Lilly and Company Join American Kidney Fund’s 2024 Corporate Membership Program at ‘Champion’ Level
August 27, 2024 11:01 ET | American Kidney Fund
ROCKVILLE, Md., Aug. 27, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today announced that Boehringer Ingelheim and Eli Lilly and Company have joined the 2024 class in AKF’s Corporate...
eledon-logo-1230.png
Eledon Pharmaceuticals Reports Preliminary Second Quarter 2024 Operating Results
August 14, 2024 17:21 ET | Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Reports Preliminary Second Quarter 2024 Operating Results
Beta Costumer Revenue Path
Oncocyte Announces Successful GraftAssure™ Beta Launch and Q2 2024 Results
August 08, 2024 16:05 ET | OncoCyte Corporation
Oncocyte Announces Successful GraftAssureTM Beta Launch and Q2 2024 Results
eledon-logo-1230.png
Eledon Provides Enrollment Update for Phase 2 BESTOW Trial Assessing Tegoprubart for the Prevention of Organ Rejection
July 29, 2024 07:00 ET | Eledon Pharmaceuticals, Inc.
Eledon Provides Enrollment Update for Phase 2 BESTOW Trial Assessing Tegoprubart for the Prevention of Organ Rejection
American Kidney Fund
American Kidney Fund Receives Major Gift from Schattner Foundation to Support Grant Programs and National Virtual Camp
July 22, 2024 09:01 ET | American Kidney Fund
ROCKVILLE, Md., July 22, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) has received a $275,000 grant from Rockville-based Schattner Foundation to support AKF’s work on behalf of the 1 in 7...
New Guidelines from
New Guidelines from the American Kidney Fund Will Help People with Chronic Kidney Disease Manage High Potassium
July 11, 2024 09:43 ET | American Kidney Fund
ROCKVILLE, Md., July 11, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today launched patient-focused guidelines to help people with chronic kidney disease (CKD) manage and treat...